<DOC>
	<DOC>NCT02270866</DOC>
	<brief_summary>This is a pilot study with a single active treatment arm. The study is designed to assess the efficacy of a portable, non-invasive neuromodulation system for the treatment of post-stroke aphasia. Both language and movement assessments will be made.</brief_summary>
	<brief_title>Effects of Neuromodulation on Verbal Fluency in Post-stroke Aphasia</brief_title>
	<detailed_description />
	<mesh_term>Stroke</mesh_term>
	<mesh_term>Aphasia</mesh_term>
	<criteria>&gt;6 months poststroke (ischemic or hemorrhagic) receptive or expressive aphasia little or no improvement in language ability in the preceding 3 months persons under the age of 18 or over the age of 75 patients with pure receptive aphasia comorbid CNS disease primary motor/oral apraxia pregnant or nursing women have a history of unstable mood disorder or unstable anxiety disorder or psychosis use of a hearing aid have a cochlear implant have a diagnosed vestibular dysfunction abuse alcohol or other drugs have had eye surgery within the previous three months or ear surgery within the previous six months have active ear infections or a perforated tympanic membrane have participated in another clinical trial within the last 30 days or are currently enrolled in another clinical trial Though not excluded, patients taking antihistamines or antinausea drugs will be encouraged not to take such medications within four hours prior to a CVS treatment. The Investigator should review other medications taken by the patient with properties that mimic antinausea or antidizziness drugs as these may reduce responsiveness of the vestibular system to caloric stimulation.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>aphasia</keyword>
	<keyword>stroke</keyword>
</DOC>